2-170716799-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000375281.4(SP5):āc.592G>Cā(p.Gly198Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000474 in 1,391,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00031 ( 0 hom., cov: 33)
Exomes š: 0.000015 ( 0 hom. )
Consequence
SP5
ENST00000375281.4 missense
ENST00000375281.4 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 4.46
Genes affected
SP5 (HGNC:14529): (Sp5 transcription factor) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within bone morphogenesis; cellular response to organic cyclic compound; and post-anal tail morphogenesis. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.25471443).
BS2
High AC in GnomAd4 at 47 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SP5 | NM_001003845.3 | c.592G>C | p.Gly198Arg | missense_variant | 2/2 | ENST00000375281.4 | NP_001003845.1 | |
ERICH2-DT | NR_110185.1 | n.376+6705C>G | intron_variant, non_coding_transcript_variant | |||||
SP5 | XM_005246542.5 | c.724G>C | p.Gly242Arg | missense_variant | 2/2 | XP_005246599.1 | ||
SP5 | XM_047444264.1 | c.364G>C | p.Gly122Arg | missense_variant | 2/2 | XP_047300220.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SP5 | ENST00000375281.4 | c.592G>C | p.Gly198Arg | missense_variant | 2/2 | 1 | NM_001003845.3 | ENSP00000364430 | P1 | |
ERICH2-DT | ENST00000662274.1 | n.859+6705C>G | intron_variant, non_coding_transcript_variant | |||||||
ERICH2-DT | ENST00000671292.1 | n.336+6705C>G | intron_variant, non_coding_transcript_variant | |||||||
ERICH2-DT | ENST00000690230.1 | n.404+6705C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000310 AC: 47AN: 151778Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
47
AN:
151778
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000153 AC: 19AN: 1239382Hom.: 0 Cov.: 33 AF XY: 0.0000149 AC XY: 9AN XY: 605950
GnomAD4 exome
AF:
AC:
19
AN:
1239382
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
605950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000310 AC: 47AN: 151778Hom.: 0 Cov.: 33 AF XY: 0.000297 AC XY: 22AN XY: 74134
GnomAD4 genome
AF:
AC:
47
AN:
151778
Hom.:
Cov.:
33
AF XY:
AC XY:
22
AN XY:
74134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2023 | The c.592G>C (p.G198R) alteration is located in exon 2 (coding exon 2) of the SP5 gene. This alteration results from a G to C substitution at nucleotide position 592, causing the glycine (G) at amino acid position 198 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Gain of methylation at G198 (P = 0.0093);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at